novel immunotherapies transforming r/r myeloma treatment: bispecifics, car-t cells & more
Published 1 year ago • 57 plays • Length 4:58Download video MP4
Download video MP3
Similar videos
-
1:53
sequencing car t-cells and bispecific antibodies in the treatment of multiple myeloma
-
5:26
novel immunotherapies for myeloma treatment
-
1:19
sequencing bispecific antibodies and car-t therapy & the evolving role of bispecifics in myeloma
-
2:16
the sequencing of novel therapies in myeloma (car-t, bispecifics, antibody-drug conjugates)
-
1:42
how to best sequence bispecific antibodies and car-t therapy in multiple myeloma
-
3:41
can novel immunotherapies cure multiple myeloma?
-
4:35
bispecific antibodies vs car t-cells for r/r multiple myeloma
-
4:02
an overview of bispecifics in r/r myeloma and their integration into the treatment landscape
-
6:23
how long will i live with multiple myeloma, and is there a cure? #myeloma
-
3:15
what is the best diet for myeloma patients to build a strong immune system?
-
1:06:04
itp: novel treatments
-
5:25
novel immunotherapies for multiple myeloma
-
1:16
how novel immunotherapies have impacted the treatment of r/r all
-
1:56
cevostamab (bfcr4350a): a novel bispecific antibody in r/r myeloma therapy
-
2:15
novel immunotherapies for the treatment of multiple myeloma
-
1:55
updates in immunotherapy for multiple myeloma: bites & novel targets
-
2:19
novel avenues for mm treatment: car t-cells, venetoclax, induction & mrd
-
3:42
novel approaches to bridging prior to car-t therapy in multiple myeloma
-
21:57
current and emerging novel immunotherapies for myeloma
-
1:37
approaching r/r multiple myeloma: novel agents and immunotherapies
-
0:54
ucartcs1: a novel allogeneic car-t therapy for myeloma
-
1:01
an update on the phase i trial of bms-986393, a novel gprc5d-targeted car-t, in r/r myeloma